Tea Reljic

1.8k citations
92 papers · 1.2k · h-index 22

Impact in

Papers in

    • Acute Myeloid Leukemia Research 11
    • Hematopoietic Stem Cell Transplantation 8
    • Chronic Lymphocytic Leukemia Research 7
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 4

Tea Reljic

86 papers receiving 1.1k citations

Peers

Tea Reljic
Comparison fields: 5 of 107
  • Hematology 343
  • Family Practice 24
  • Genetics 130
  • Transplantation 26
  • Dermatology 71
Replace Mitsumasa Kishimoto with:
Mitsumasa Kishimoto Japan
Anthony D. Sung United States
C. Christopher Hook United States
G Kraag Canada
K Downs Australia
Thomas V. Jones United States
Elizabeth Tanjong Ghogomu Canada
Bente Glintborg Denmark
Dilli Ram Poudel United States
Paolo Angelo Cortesi Italy
Tea Reljic relative to Mitsumasa Kishimoto Japan Mitsumasa Kishimoto's profile →
Citations per field
00.5×8.7×
Mitsumasa Kishimoto · 1×
Citations per year

Countries citing papers authored by Tea Reljic

Since Specialization
Citations

This map shows the geographic impact of Tea Reljic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tea Reljic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tea Reljic more than expected).

Fields of papers citing papers by Tea Reljic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tea Reljic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tea Reljic. The network helps show where Tea Reljic may publish in the future.

Co-authors

The 25 scholars most cited alongside Tea Reljic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tea Reljic Line = papers co-authored together Tea Reljic links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201473
2 201151
3 201248
4 201441
5 201339
6 201439
7 201338
8 201433
9 201333
10 201333
11 201532
12 201531
13 201931
14 201831
15 201830
16 201330
17 201328
18 201828
19 201825
20 201725

About Tea Reljic

Tea Reljic is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Oncology, having authored 92 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (9 papers), Hematopoietic Stem Cell Transplantation (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), T-cell and Retrovirus Studies (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Traumatic Brain Injury Research (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (343 citations), Family Practice (24 citations), Genetics (130 citations), Transplantation (26 citations) and Dermatology (71 citations). Tea Reljic has collaborated with scholars based in United States, Lebanon and India. Frequent co-authors include Ambuj Kumar, Benjamin Djulbegović, Mohamed A. Kharfan‐Dabaja, Mehdi Hamadani, Ernesto Ayala, Taiga Nishihori, Rahul Mhaskar, Ali Bazarbachi, Hemant S. Murthy and Jeffrey E. Lancet. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Blood, PLoS ONE, Journal of Clinical Epidemiology and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact